GEXVal Raises JPY 300M and Partners with Alfresa Holdings
2025/1/16
GEXVal Inc.January 16, 2025 GEXVal Completes Additional Funding of JPY 300 Million in Series C Extension Round […]
FRAXA Research Foundation Features GEXVal's Development Program
2025/1/6
GEXVal Inc.January 6, 2025 We are delighted to announce that FRAXA Research Foundation1) has featured GEXVal I […]
GEXVal Selected for AMED’s ‘Strengthening Program for Pharmaceutical Startup Ecosystem’
2024/12/16
GEXVal Inc.16 December, 2024 We are delighted to announce that GEXVal Inc.'s planned global Phase 2a Proof of […]
GEXVal Selected as Finalist for CITELINE JAPAN AWARDS 2024 in Categories: EXECUTIVE OF THE YEAR & FINANCING DEAL OF THE YEAR
2024/10/8
GEXVal Inc.October 8, 2024 We are honored to announce that GEXVal Inc. (President and CEO: Juran Kato, PhD; […]